Mia's Feed
Medical News & Research

Persistent Use of Unnecessary Cancer Screenings Despite Updated Guidelines, New Study Reveals

Persistent Use of Unnecessary Cancer Screenings Despite Updated Guidelines, New Study Reveals

Share this article

A new study reveals that unnecessary cancer screenings persist for years after guidelines advise against them, leading to overdiagnosis and increased healthcare costs. The research emphasizes the need for better implementation of evidence-based practices.

2 min read

A recent study highlights that unnecessary and potentially harmful cancer screenings continue for years even after official guidelines advise against them. Published in BMJ Quality & Safety, the research examines the lag between the dissemination of updated screening recommendations and their actual adoption in clinical practice, which can take up to 13 years or longer. This delay allows many patients to be subjected to overdiagnosis, unnecessary treatments, pain, anxiety, and increased healthcare costs.

The study emphasizes that for certain cancers, such as cervical and prostate cancer, the reduction in screening rates has been slow despite clear guidelines. For example, screening for cervical cancer in women under 21 or over 65 dropped by 50% within a year, but in women over 65, it took over a decade to reach similar reductions. Similarly, although guidelines have recommended against prostate cancer screening in men aged 70 and above since 2012, screening rates have not decreased sufficiently.

Barriers to stopping unnecessary screenings include ingrained medical routines, patient expectations, and the challenge physicians face when changing long-standing practices. The lack of mechanisms to accurately track the impact of updated guidelines on screening behaviors for cancers like ovarian, thyroid, testicular, and pancreatic further complicates the issue.

Guidelines for cancer screenings are established by the U.S. Preventive Services Task Force, which grades the appropriateness of tests based on evidence, with 'D' grades indicating tests that should generally not be performed due to lack of benefit or potential harm. Despite periodic updates, the persistence of outdated screening practices underscores the need for better implementation strategies and education to reduce low-value procedures.

Ultimately, the study advocates for increased efforts to align clinical practice with current evidence-based guidelines, to minimize patient harm, optimize resource use, and improve healthcare outcomes.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Breakthrough in Lab-Grown Kidney Development Advances Towards Synthetic Organs

Researchers have developed more mature and complex lab-grown kidney structures, paving the way for synthetic organs and improved kidney disease models. This breakthrough enhances our understanding of kidney development and opens new avenues for transplantation and disease treatment.

Innovative Portable Brain Monitoring Technology Offers New Hope for Dementia Detection

A groundbreaking portable brain monitoring system using broadband near-infrared spectroscopy shows promise for early dementia detection by assessing brain metabolism and blood oxygenation in a noninvasive manner.

Study Finds Urban Missouri Areas Have Higher Prescriptions of High-Dose Opioids

A recent study reveals that urban areas in Missouri have higher rates of high-dose opioid prescriptions, increasing risks for opioid use disorder among residents. The research emphasizes demographic and regional factors influencing prescribing habits.

Innovative Cell Therapy Shows Promise in Treating ALS Patients

A novel cell therapy developed by Dr. Parmar shows promising safety and efficacy for ALS and other diseases, opening new horizons in regenerative medicine.